Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data

83Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We present Beyondcell, a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq data and proposing cancer-specific treatments. Our method calculates an enrichment score in a collection of drug signatures, delineating therapeutic clusters (TCs) within cellular populations. Additionally, Beyondcell determines the therapeutic differences among cell populations and generates a prioritised sensitivity-based ranking in order to guide drug selection. We performed Beyondcell analysis in five single-cell datasets and demonstrated that TCs can be exploited to target malignant cells both in cancer cell lines and tumour patients. Beyondcell is available at: https://gitlab.com/bu_cnio/beyondcell.

Cite

CITATION STYLE

APA

Fustero-Torre, C., Jiménez-Santos, M. J., García-Martín, S., Carretero-Puche, C., García-Jimeno, L., Ivanchuk, V., … Al-Shahrour, F. (2021). Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data. Genome Medicine, 13(1). https://doi.org/10.1186/s13073-021-01001-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free